Sei Investments Co. boosted its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 72.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 274,011 shares of the company's stock after purchasing an additional 115,403 shares during the period. Sei Investments Co. owned approximately 0.15% of Doximity worth $14,629,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of the stock. Handelsbanken Fonder AB lifted its position in Doximity by 0.7% during the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company's stock worth $1,586,000 after acquiring an additional 200 shares during the period. UMB Bank n.a. lifted its holdings in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after purchasing an additional 235 shares during the period. Fielder Capital Group LLC lifted its holdings in shares of Doximity by 4.5% during the fourth quarter. Fielder Capital Group LLC now owns 5,488 shares of the company's stock worth $293,000 after purchasing an additional 235 shares during the period. Larson Financial Group LLC boosted its position in Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after buying an additional 250 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in Doximity by 20.6% in the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company's stock worth $93,000 after buying an additional 296 shares during the period. Institutional investors and hedge funds own 87.19% of the company's stock.
Doximity Trading Up 2.2 %
Doximity stock traded up $1.24 during mid-day trading on Wednesday, hitting $57.96. The company's stock had a trading volume of 1,819,929 shares, compared to its average volume of 1,940,780. The stock's fifty day moving average is $65.63 and its two-hundred day moving average is $54.84. The firm has a market capitalization of $10.82 billion, a PE ratio of 57.96, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on DOCS. The Goldman Sachs Group raised their target price on shares of Doximity from $58.00 to $80.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Leerink Partnrs upgraded Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Mizuho raised their target price on Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Stephens assumed coverage on Doximity in a research note on Friday, December 20th. They issued an "equal weight" rating and a $55.00 price target for the company. Finally, Leerink Partners upgraded Doximity from a "market perform" rating to an "outperform" rating and raised their price objective for the company from $60.00 to $90.00 in a report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Doximity presently has an average rating of "Moderate Buy" and a consensus price target of $64.22.
Get Our Latest Stock Analysis on Doximity
Insider Activity
In related news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 37.40% of the company's stock.
About Doximity
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Further Reading

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.